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Natural products that act as highly specific, small-
molecule protein-binding agents and as modulators
of protein-protein interactions are highly complex and
exhibit functional groups with three-dimensional and
stereochemical diversity. The complex three-dimen-
sional display of chiral functional groups appears to
be crucial for exhibiting specificity in protein binding
and in differentiating between closely related pro-
teins. The development of methods that allow a high-
throughput access to three-dimensional, skelatally
complex, polycyclic compounds having few asym-
metric diversity sites is essential and a highly chal-
lenging task. In the postgenomic chemical biology
age, in which there is a great desire to understand
protein-protein interactions and to dissect protein
networking-based signaling pathways by small mole-
cules, the need for developing “stereocontrolled, di-
versity-oriented synthesis” methods to generate nat-
ural product-like libraries is of utmost importance.
Introduction
Synthetic organic chemistry is a powerful discipline
that plays a pivotal role in biomedical research. It pro-
vides access to new chemical entities such as natural
product analogs, natural product-like scaffolds, and
unnatural structures that can be used as small-mole-
cule chemical probes for understanding biological events
[1, 2]. The synthetic community has long been engaged
in developing efficient methods to generate these ar-
chitecturally complex natural products and their more
simple analogs. In the past few decades, this has
driven the need for developing efficient stereo- and en-
antioselective synthetic methods to keep up with the
growing demand for having three-dimensional, archi-
tecturally complex molecules readily available [3].
Combinatorial chemistry came on board with the
promise of providing rapid access to a wide variety of
small molecules, either by solution- or solid-phase syn-
thesis [4–6]. In general, this area of research has been
successful in accessing rather simple compounds. De-*Correspondence: prabhat.arya@nrc.ca
3 Present address: MDS, Inc., 2350 Cohen Street, Saint-Laurent,
Montréal, Québec H4R 2N6, Canada.veloping high-throughput synthesis methods leading to
architecturally complex natural products and their sim-
ple analogs is a daunting task, resulting in little success
to date [7–10]. Although solution-phase combinatorial
chemistry has been utilized [11], solid-phase synthesis,
either by parallel or split-and-mix synthesis, appears to
be more useful in library generation [12].
Over the years, three-dimensional, architecturally
complex natural products have been widely utilized as
small-molecule probes for understanding protein func-
tion [13]. Imbedded in these natural products are a
number of highly diverse, chiral functional groups act-
ing as potential sites for protein binding. With the grow-
ing demand for having access to small molecules for
use as highly specific modulators of protein function
and protein-protein interaction-based signaling path-
ways, the need for charting a chemical space currently
occupied by natural products has also grown. Diver-
sity-oriented synthesis is aimed at reaching this objec-
tive, i.e., to populate the chemical space that is cur-
rently not available by the conventional combinatorial
chemistry [14].
In the postgenomic chemical biology age, under-
standing complex biological processes by small-mole-
cule probes is a highly desirable activity. In contrast
to the classical biochemical tools, the use of chemical
probes is highly attractive for understanding dynamic
biological processes because of the probe’s ability to
induce subtle, and generally reversible, changes in pro-
tein dynamics [15–21]. Obtaining rapid access to the
newly generated stereochemically and skeletally di-
verse natural product-like derivatives is a limiting factor
[22, 23]. Consequently, for example, biological research
that involves signaling pathways based on protein-pro-
tein interactions has not achieved much success in the
past [24]. A lack of useful chemical probes available
as specific modulators of these pathways has been a
contributing factor to this limited success [25].
The term “diversity-oriented synthesis (DOS)” was
coined by Stuart Schreiber, and DOS is aimed at gen-
erating natural product-like compounds in a high-
throughput manner [14, 23]. In particular, DOS is aimed
at obtaining natural product-like compounds that are (i)
easy to access, (ii) rich in dense, chiral functional
groups, and (iii) rich in stereochemically and three-
dimensional, skeletally diverse architectures. DOS was
developed to address the growing need for having
rapid access to skeletally diverse natural product-like
derivatives that could be further utilized in library gen-
eration. Unlike the traditional combinatorial approaches
that were focused on the library generation of aromatic
and heterocyclic products, building three-dimensional,
structurally complex stereo- and enantioselective reac-
tions on solid phase is one of the major areas in DOS.
In general, the libraries generated by DOS are utilized
as small-molecule chemical probes for understanding
cellular processes and are not biased toward a specific
biological target. Within the scope of this review, com-
pounds that belong to the chemical space currently oc-
Chemistry & Biology
164cupied by natural products may be considered as natu- o
tral product-like compounds.
bThe goal of this review is to highlight the differences
tbetween two approaches, (i) natural product-guided
ccombinatorial chemistry, in which natural product ana-
slogs of individual natural products are obtained [26–29],
tand (ii) DOS-based combinatorial chemistry, in which
cthree-dimensional, skeletally diverse natural product-
tlike derivatives are synthesized. This is by no means
iintended to be an extensive review covering these two
utopics. Using selected examples, the objective here is
tto reflect upon the fundamental differences in design
strategies and different expectations of both research
eefforts.
c
T
Natural Product-Guided Combinatorial Chemistry: e
Libraries of Analogs of Individual Natural Products t
With the goal of obtaining simple analogs, the unique d
structural architectures of bioactive natural products e
present tremendous challenges in developing a combi- f
natorial chemistry program. Based on the fact that nat- t
ural products have been providing a major source of a
lead compounds in drug discovery research, there is a s
growing interest in developing combinatorial chemistry a
(high-throughput solution- or solid-phase synthesis) (
that utilizes the core structures. a
An application of a stereocontrolled Pictet-Spengler i
reaction on solid phase was reported by Kapoor and g
coworkers [30]. Using a high-throughput, microscopy- a
based, cellular screen, the discovery of a small mole- c
cule (HR22C16 [1.1]; see Figure 1) as an inhibitor of cell v
ldivision led to the development of a solid-phase libraryFigure 1. Kapoor and Coworkers’ Solid-
Phase Synthesis of HR22C16 Analogs that
Utilized a Stereocontrolled Pictet-Spengler
Approach
Taken from the article by Hotha et al. [30].
(A) Schematic representation of the assay.
Vertebrate cells (BS-C-1) in multiwell plates
are stained for the actin cytoskeleton and
are imaged from below by using a 4× ob-
jective.
(B) The effect of a compound that causes no
morphological change.
(C and D) (C) The effect of HR22C16 and (D)
the configuration of microtubules in a (left)
control cell and a (right) HR22C16-treated
cell.f its analogs. One of the library members was found
o be 9-fold more potent as an inhibitor of Eg5 protein
inding agent than the parent compound HR22C16. In
heir approach (Figure 1), the amino acid derivative an-
hored onto the solid support, 1.2 (see Figure 1), was
ubjected to N-Boc removal. The secondary amine was
hen reacted with a variety of aldehydes, giving the tri-
yclic trans product as the major diastereomer (9:1 ra-
io). Upon allyl deprotection and reaction with several
socynates, the tetracyclic hydantoin products (1.3, Fig-
re 1) were obtained in good yields after release from
he solid support.
An application of the domino reaction to obtain sev-
ral analogs of the natural product emetine (2.1, all 2.X
ompounds are shown in Figure 2) was reported by
ietze and coworkers [31]. They utilized an enantiosel-
ctive hydrogenation to obtain enantiomerically pure
etrahydroisoquinolines (2.3 and 2.4) from 2.2. The
omino reaction of 2.5 with Meldrum acid (2.6) and the
nol ether (2.7) provided the lactone (not shown in the
igure). Upon treatment with base and after hydrogena-
ion, the benzoquinolizidine skeleton (2.8) was obtained
s a mixture of diastereomers. These compounds were
eparated by column chromatography. Upon further re-
ction of 2.8 with 2-(3,4-dimethoxyphenyl)ethylamine
2.10), 2.8 provided the corresponding imines (2.11) via
mide formation by Bischler-Napieralski reaction. The
mines were then subjected to enantioselective hydro-
enation, giving the stereocontrolled products, 2.12
nd 2.13. Thus, an application of a domino reaction
ombined with enantioselective hydrogenation pro-
ided a solution-phase library synthesis of several ana-
ogs of emetine alkaloid.
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Combined with Enantioselective Hydrogena-
tion to Obtain Emetine Analogs by Tietze
and Coworkers
See [31].Sesquiterpenoid dysidiolide (3.5, all 3.X compounds
are shown in Figure 3) is a naturally occurring inhibitor
of the dual specificity Cdc25 protein phosphatase fam-
ily that plays a crucial role in the regulation of the cell
cycle. It has a decalin-type framework that carries a
lipophilic side chain terminating in an olefin, and a hy-
drophobic side chain incorporating an alcohol and a
γ-hydroxybutenolide moiety. For the solid-phase syn-
thesis of 6-epi-dysidiolide [32], polymer bound diene,
3.1, was subjected to Diels-Alder reaction conditions at
−78°C with triglic aldehyde, which had been converted
into a quasi C2 symmetric, chiral acetal in order to en-
hance the stereoselectivity. After hydrolytic removal of
the chiral auxiliary, aldehyde 3.2 was obtained as a mix-
ture of four isomers formed in the ratio 87 endo:4
endo#:9 exo:0.1 exo#. The carbon chain of aldehyde 3.2
could then be elongated in a two-step sequence of the
Wittig reaction and hydrolysis of the enol ether formed
therein. However, the reaction did not go to completion
on the solid support. An alternative route employing the
corresponding phosphonium chloride and KO-t-Bu as
a base resulted in clean transformation, and further
hydrolysis of the enol ether was carried out with pyri-
dinium para-toluenesulfonate (PPTS)/tetrahydrofuran
(THF)/H2O. Nucleophilic addition of furyllithium to resin
bound aldehyde 3.3 resulted in 3.4 as a 2:1 mixture of
diastereomers. Subsequently, furan 3.4 was oxidized to
a butenolide derivative with singlet oxygen in the pres-
ence of a mild base. Finally, release of product 3.5 from
the polymeric support was achieved in a traceless
manner by performing an olefin metathesis with 10
mol% Grubbs’ catalyst.
The next goal was to obtain the analogs of dysidio-
lide that differ from the natural product in chain length
and in the substitution pattern. Dysidiolide analogs with
a shortened carbon chain were obtained via the addi-
tion of 3-lithiofuran to aldehyde 3.6, thus giving com-
pound 3.7. This was then subjected to oxidation with
bengal rose and subsequent cleavage from the solid
support by olefin metathesis. Subsequent oxidationwith ortho-iodoxybenzoic acid resulted in the corre-
sponding ketone, 3.9. In a second series of the experi-
ments, dysidiolide with a double bond between the an-
ellated ring and the hydroxyl butenolide (3.12) was also
synthesized. Treatment of 3.6 with the ylide obtained
from furylmethyltriphenylphosphonium bromide by re-
action with KO-t-Bu in THF at room temperature re-
sulted in 3.11. The furan ring was oxidized with singlet
oxygen, and the olefinic dysidiolide analog 3.12 was
released by olefin metathesis. Finally, compound 3.8
was obtained by a Grignard reaction of 3.6 with 3-bro-
momethylfuran and Mg in THF. The product of the Grig-
nard reaction (3.8) was then subjected to oxidation and
cleavage from the solid support by olefin metathesis.
Subsequent oxidation resulted in 3.10. The same reac-
tion sequence was also carried out on the homoalde-
hyde system. The dysidiolide analogs were then in-
vestigated as inhibitors for the protein phosphatase
Cdc25c and in cellular cytotoxicity assays. Most of the
analogs exhibit inhibition properties. In conclusion, a
natural product-derived library was obtained through a
multistep synthesis on solid phase, and this library de-
livered several potent, biologically active compounds.
1α, 25-dihydroxyvitamin D3 (4.1, all 4.X compounds
are shown in Figure 4) is a steroid hormone and a bio-
active metabolite of vitamin D3. This compound is
known to exhibit several biological activities that range
from the regulation of calcium and phosphorus metab-
olism, to modulation of cell differentiation and prolifera-
tion, to regulation of the immune system. To generate
several analogs of this steroid hormone in order to
study its biological functions, Takahashi and coworkers
[33, 34] developed the solid-phase synthesis of the vi-
tamin D3 skeleton. A key strategy in their approach was
to immobilize the CD ring system onto the solid support
by using the primary hydroxyl group, 4.2. This scaffold
could be coupled first to the A ring moiety, 4.3, and,
finally, to the side chain extension with the use of Grig-
nard 4.4. The primary hydroxyl group was immobilized
onto the solid support by using a sulfonylchloride
Chemistry & Biology
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Phase Synthesis of Dysidiolide-Derived Pro-
tein Phosphatase Inhibitors
See [32].linked to a polystyrene resin. As shown in Figure 4, the b
(CD ring building block having a free hydroxyl group,
4.5, was prepared by solution synthesis. It was then h
rreacted with chlorosulfonyl polystyrene resin, 4.6, giv-
ing the immobilized CD ring skeleton, 4.7. Compound t
g4.7 was then subjected to a Horner-Wadsworth-Emmons
reaction with 4.8 to obtain the coupled product, 4.9. p
wFinally, upon reaction with the Grignard reagent pre-
pared from 4.10, followed by deprotection under mildly a
iacidic conditions, compound 4.11 was obtained. By
varying the CD ring scaffold, by varying the A ring skel- d
aeton, and by using different side chains, a library of 72
compounds was synthesized by utilizing the radiofre- r
5quency-encoded IRORI technology.
Saframycin A (5.1, all 5.X compounds are shown in l
cFigure 5) is a structurally complex alkaloid and belongs
to a member of a series of natural antiproliferative q
aagents that contains a cyanopiperazine scaffold or its
functionalized equivalent [35]. Myers and coworkers s
t[36, 37] developed a solid-phase synthesis to obtain
rapid access to saframycin analog 5.2. The synthesis began with attachment of the antimorpholino nitrile
5.3) onto the solid support. The silylation of the primary
ydroxyl group with 4-(chlorodiisopropyl-silyl)polysty-
ene provided the resin bound intermediate, 5.4. Selec-
ive deprotection of the tert-butyldimethylsilyl ether
roup and subsequent removal of the Fmoc group with
iperidine afforded the phenolic amine. Upon treatment
ith N-protected α amino aldehyde, 5.5, the phenolic
mine provided the corresponding resin-supported im-
ne. Warming the imine in a saturated solution of anhy-
rous lithium bromide in 1,2-dimethoxyethane induced
stereoselective Pictet-Spengler cyclization reaction,
esulting in the cis-tetrahydroisoquinoline derivative,
.6. The secondary amine group of tetrahydroisoquino-
ine intermediate 5.6 formed in the Pictet-Spengler
yclization was then reductively methylated. Subse-
uent deprotection of the phenol and of the primary
mine produced an intermediate, 5.7, which was then
ubjected to a second Pictet-Spengler cyclization reac-
ion upon exposure to N-Fmoc glycinal. The resulting
is-tetrahydroisoquinoline derivative, 5.8, was formed
Review
167Figure 4. Takahashi and Coworkers’ Solid-
Phase Approach to Vitamin D3
See [33, 34].in quantitative yield with the required cis stereochemis-
try in the newly formed ring. In the key step, the bis-
tetrahydroisoquinoline intermediate, 5.8, was subjected
to cyclization autorelease [38, 39] by warming at 55°C
in the presence of ZnCl2 for 1.5 hr. This transformation
is presumed to involve (i) reversible morpholinium ion
formation through an expulsion of cyanide, (ii) internal
capture by cyclization of the secondary amino group
formed in the final Pictet-Spengler cyclization reaction,
and (iii) subsequent extrusion of the resin bound mor-
pholine linker through its secondary point of attach-
ment (i.e., the amino group). The newly liberated imi-
nium ion is then captured in solution by the cyanide,
providing the saframycin analog, 5.9. A key feature ofthis reaction is the distereospecificity. Further diversity
was introduced by employing a range of alkyl bromides
in the N-alkylation of resin 5.7 and varying the aldehyde
reactant in the second Pictet-Spengler cyclization reac-
tion. Thus, a 16-membered library of saframycin A ana-
logs was prepared by parallel synthesis.
The spiroketal moiety is present in several bioactive
natural products, such as spongistatins (6.1, all 6.X
compounds are shown in Figure 6) and okadaic acid
(6.3). Therefore, it is not surprising that this scaffold has
received attention from the combinatorial chemistry
community. In a recent study reported by Waldmann
and coworkers [40], asymmetric, aldol reaction-medi-
ated, solid-phase synthesis [41, 42] was utilized in the
Chemistry & Biology
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ective Solid-Phase Synthesis of Saframycin
Analogs
See [36, 37].generation of a library of spiroketal derivatives. Chiral p
tboron Z-enol ether 6.6 mediated a syn-aldol reaction
with an aldehyde anchored on the solid support, pro- i
sviding product 6.7. The E-Enol ether, 6.8, was then gen-
erated by using established methods from aldol litera- a
ature such that upon reaction with various aldehydes,
only the anti-aldol products were obtained (only two c
rexamples are shown, 6.13 and 6.14). Following func-
tional group modification, 6.8 could be converted into i
sdifferent spiroketals, 6.9–6.12. Thus, a combination of
asymmetric syn- and anti-aldol reactions on solid i
pphase was utilized in generating different spiroketals
and is a powerful approach in the generation of com- m
dplex spiroketal-derived libraries.
o
tDiversity-Oriented Synthesis-Based Combinatorial
Chemistry: Libraries of Natural s
oProduct-like Compounds
The combinatorial chemistry examples discussed in the t
previous section allow access to small-molecule ana-
logs of a given bioactive natural product, which tends c
gto populate the chemical space currently occupied by
the existing natural products. Parallel to this approach, p
mthe goal of diversity-oriented synthesis is to populate the
unexplored chemical space by developing methods o
ithat allow rapid access to natural product-like com-ounds having three-dimensionally complex architec-
ures. To meet some of the emerging challenges that
nvolve the understanding of protein networking-based
ignaling pathways, the need for small molecules that
re capable of specifically modulating protein function
nd protein-protein interactions is likely to grow. The
ombinatorial chemistry program in DOS utilizes ste-
eo- and enantioselective organic synthesis tools and
s expected to provide small molecules that are rich in
tereochemically defined polyfunctional groups and
n three-dimensional, conformationally diverse natural
roduct-like skeletons. Stuart Schreiber’s team is the
ain ambassador of the DOS approach that was intro-
uced to the synthetic community in late 90’s. This area
f research is a relatively new direction in the combina-
orial chemistry community. Selected examples from
everal research groups discussed herein are indicative
f a growing interest in this area and different strategies
hat have been successfully developed to date.
A recent example of DOS used to obtain small mole-
ules having stereochemically defined, chiral functional
roups and conformationally diverse structures was re-
orted by Schreiber and coworkers [43]. The develop-
ent of successful methods on solid phase by the use
f alkylsilyl macrobeads (500–560 m) was then utilized
n library generation [44]. The furaldehyde was immobi-
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169Figure 6. Bioactive Spiroketal Moieties Em-
bedded in Spongistatin and Okadaic Acid
Waldmann and coworkers’ [40] enantiosel-
ective, aldol-based solid-phase synthesis of
the spiroketal library.lized onto the macrobead-based solid support (7.1, all
7.X compounds are shown in Figure 7), which was then
subjected to Evans asymmetric aldol reaction condi-
tions, giving the aldol product, 7.2. In a different experi-
ment, the aldehyde was subjected to chain extension,
leading to the protected allylic alcohol derivative, 7.3,
required for the Sharpless asymmetric dihydroxylation
reaction to obtain 7.4. Compounds 7.2 and 7.4 are use-
ful intermediates to obtain skeletally diverse derivatives.
For example, an opening of the substituted furan ring
could result in a linear skeleton having a trans-olefinic
moiety, 7.6. The NBS-mediated oxidative ring expan-
sion of the aldol product, 7.2, provided the stereo-
chemically defined pyranone derivative, 7.7, after the
PPTS-catalyzed dehydration. Under similar oxidative
ring expansion conditions, diol 7.4 was converted into
the bicyclic derivative, 7.8. Thus, starting from a com-
mon furaldehyde starting material, several skeletally di-
verse compounds could be obtained that utilize the
substituted furan moiety as a source for creating the
skeletal diversity. After these reactions were developed
on solid phase by using alkylsilyl macrobeads, they
were then used to generate a library by split-and-mix
synthesis approach. Figure 7 also outlines an extension
of this approach that was further tried on bromobenzo-furaldehyde, 7.10. The incorporation of the bromo func-
tional group on the furan moiety provides an additional
site that could be further subjected to structural diversi-
fication. Overall, this is an excellent example of ste-
reocontrolled DOS in which small-molecule libraries
have been obtained that combine the use of different
building blocks and an approach to obtain stereochem-
ically and skeletally diverse natural product-like archi-
tectures.
Although commonly utilized in classical synthesis
projects, the use of enanantioselective catalysis in DOS
has not been explored extensively. To this goal, Sta-
venger and Schreiber [45] reported the enantioselective
synthesis of 2H-pyran derivatives on solid phase that
utilized the C2-symmetry, chiral, bis(oxazoline)-derived
Lewis acids (8.4 and 8.5, all 8.X compounds are shown
in Figure 8). In their approach, the vinyl ethers anchored
onto encoded alkylsilyl macrobeads (8.2, 8.3, 8.8, and
8.9) were reacted with the ketoester (8.1), giving dif-
ferent 2H-pyrans (8.6, 8.7, 8.10, and 8.11). The use of
encoded split-and-mix technology on macrobeads al-
lowed the authors to obtain a library of 4320 com-
pounds. The enantioselective cycloaddition reaction
worked well on solid phase, and the products were ob-
tained in good yields and with high %enantiomeric ex-
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proach to Obtain Skeletally Diverse Natural
Product-like Compounds
See [43].cess (%ee). Along with other compounds, this library c
bwas arrayed and tested for the inhibition of a transcrip-
tion factor that requires the disruption of either DNA- d
aprotein or protein-protein interactions. This DOS library
was tested for small-molecule binding to modulate the d
ctranscriptional activity of Hap3p [46]. This is a subunit
of the yeast hap2/3/4 transcriptional factor complex a
tand is involved in aerobic respiration and the nutrient
response signaling network. The small-molecule micro- a
jarray was probed with purified Hap3p-GST fusion pro-
tein, and the color detection was achieved by using a i
ilabeled antibody against the GST portion of the fused
protein. Interestingly, two DOS library members (see p
mFigure 8) were identified as positive compounds. In a
control experiment to examine the binding with the GST s
tprotein, one of the two compounds showed positive
results. Finally, the binding of a DOS library member e
t(Heptamide A) was confirmed by surface plasmon reso-
nance studies. w
fIn another study, Schreiber and coworkers reported
the diversity-oriented synthesis of a library of medium- 7
fsized rings containing an atrop-diastereodefined biaryl
moiety [47, 48]. Natural products such as Vancomycin e
o(structure not shown) and Pterocaryanin C (9.1, all 9.Xompounds are shown in Figure 9) contain asymmetric
iaryl moieties within 10- and 12-membered rings. Al-
ehyde 9.3 was prepared through loading onto the
lkylsilyl macrobeads. This was then subjected to re-
uctive amination, followed by alkylation of the se-
ondary amine to obtain 9.4. Having two brominated
ryl moieties in 9.4, the stage was now set to explore
he carbon-carbon bond-forming reaction. Thus, after
halogen metal exchange reaction, 9.4 was then sub-
ected to conditions used to generate the cyclic cuprate
ntermediate (structure not shown). Upon oxidation, this
ntermediate provided 9.5, an atropstereocontrolled
roduct having an asymmetric biaryl moiety (diastereo-
eric ratio = 6:1 [P:M]) with a 10-membered ring, on
olid phase. Interestingly, upon heating compound 9.5,
he authors were able to reverse the atropdiastereom-
ric ratio to 1:7 (P:M). Using encoded split-and-mix
echnology, a library of approximately 1400 compounds
as obtained. This library was used to explore the ef-
ects of small molecules on the development of (i)
-day-old Arabidopsis thaliana seedlings and (ii) Zebra-
ish embryos. As shown in Figure 9, one library member
xhibited inhibition of plant development, whereas its
ther diastereomer showed very weak inhibition ef-
Review
171Figure 8. Schreiber and Coworkers’ Ap-
proach to 2H-Pyran Derivatives
(A) An application of enantioselective Lewis
acid catalysis on solid phase to obtain a li-
brary of substituted 2H-pyrans.
(B) Small-molecule microarray of compounds
obtained from a substituted 2H-pyran library
(taken from [46]).
See [45, 46].fects. This effect presumably arises from the inhibition
of chlorophyll and/or carotenoid biosynthesis. In an-
other assay, one of the library members was found to
inhibit the development of Zebrafish embryos at 100
nM. By the second day, they exhibited lower pigmenta-
tion, weak hearts, abnormal brains, and misshapen
jaws. In one example, the M-diastereomer had an effect
on the cardiovascular system, whereas the P-diaste-
reomer showed no effect at all.
With the goal of obtaining small molecules having
skeletally diverse structures with stereodefined func-
tional groups, Schreiber and coworkers [49, 50] devel-
oped a boronic ester annulation strategy. The transes-
terification of unsaturated boronic esters with allylic or
propargylic alcohols (10.2 and 10.5, all 10.X com-
pounds are shown in Figure 10), prepared from alde-
hydes (10.1), transiently provided mixed organoboronic
esters (10.3 and 10.6) that could then be trapped by
using ring-closing metathesis (RCM) to afford cyclic bo-
ronic esters (10.4 and 10.7). Oxidation, cycloaddition,
and allene-forming hydroxyalkylation of the resulting
cyclic boronic esters further illustrate the diversity-gen-
erating, branching pathways. For example, 3-hydroxy-
benzaldehye loaded onto 500–600 m alkylsilyl-deri-
vatized polystyrene macrobeads (10.8) was subjected
to 1-propynylmagnesium bromide to yield propargylic
alcohol, 10.9. Upon treatment of 10.9 with the unsatu-
rated boronic ester, a mixed organoboronic ester re-
sulted, which was then trapped by RCM to afford the
dienylic boronic ester, 10.10. Stereoselective Diels-
Alder cycloaddition of 10.10 provided access to polycy-
clic derivative 10.11. Finally, the resin was cleaved by
using HF-pyridine to yield polycyclic derivative 10.12.This boronic ester approach to diversity-oriented syn-
thesis yielded complex structures containing multiple
rings, four stereogenic centers, and unsaturated units
in just four steps. As an extension, the allenylation reac-
tion of cyclic boronic acid was also investigated. Annu-
lation product 10.13 was converted into trisubstituted
allene, 10.14, by simple heating. A closed transition
state was postulated as leading to the formation of
10.14 as the major isomer. This reaction was then tried
on solid support by using alkylsilyl macrobeads. Com-
pound 10.16 reacted with the immobilized 3-hydroxyl-
benzaldehyde, 10.15, to produce product 10.17 upon
cleavage from the support. The successful demonstra-
tion of an allenylation reaction on macrobead-based
solid phase could further be utilized in the library gener-
ation by split-and-mix synthesis protocols. It is interest-
ing to note the stereocontrolled nature of this reaction
when tried on solid phase.
In another example, Schreiber and coworkers [51]
developed an efficient stereoselective synthesis of tri-
cyclic compounds by exploring Ferrier and Pauson-
Khand reactions [52–54] on a glycal template. This
methodology was utilized in a stereoselective synthesis
of a library of 2500 compounds aided by a split-and-
mix synthesis strategy and a “one-bead, one-stock so-
lution” technology platform. Solid-phase synthesis was
performed on 500–560 m polystyrene, alkylsilyl-deri-
vatized macrobeads. The initial starting compound for
the loading, 11.4 (all 11.X compounds are shown in Fig-
ure 11), was synthesized according to the reaction
shown in Figure 11. Ferrier reaction of 3,4,6-tri-O-ace-
tyl-D-glucal (11.1) with (S)-1[tert-butyldiphenylsilyl)oxy]-
3-buytyn-2-ol (11.2) gave the pseudoglucal, 11.3, as the
Chemistry & Biology
172Figure 9. Schreiber and Coworkers’ Ap-
proach
(A) A library of small molecules containing
atrop-diastereodefined, medium-sized rings.
(B) (a and b) Plant and (c and d) Zebrafish
assay: (a) 7-day-old Arabidopsis seedlings
germinated on agar containing 1% DMSO
and a small-molecule library member (10 m).
(b) 7-day-old control experiment. (c) Syn-
chronized Zebrafish embryos upon treat-
ment with a small-molecule library member
(100 nM); these embryos are slow to de-
velop, and they exhibit lower than normal
pigmentation, weak hearts, abnormal brains,
and misshapen jaws. (d) Synchronized em-
bryos upon treatment with the same library
member (5 m); Zebrafish look indistinguish-
able from untreated controls (taken from [48]).
See [47, 48].α anomer exclusively, whereas the Ferrier reaction with 1
rthe (R)-isomer gave a mixture of both the α and β iso-
mers in a ratio of 5:1 from which the α anomer could v
be isolated by column chromatography. Removal of
the tertiary-butyldimethylsilyl protecting group, followed a
cby protection of the primary hydroxyl functionality as
4-butyloxybenzyl (BOB) ether and deacetylation, re- t
asulted in BOB ether 11.4. The BOB group can be easily
deprotected by 2,3-dichloro-5,6-dicyano-1,4-benzoqui- g
dnone without harming the encoding tags. Ether 11.4
was then loaded onto 500–600 m polystyrene, alkylsi- m
mlyl-derivatized macrobeads, giving 11.5. The first solid-
phase diversity step (R1) is the functionalization of the p
i4-hydroxy group of the pseudoglucal, 11.5. Phenyliso-
cyanate reacted quantitatively to afford the carbamate, m
(and deprotection of the BOB group afforded the alco-
hol 11.6, which was the second point of diversity. The o
shydroxyl group was first converted to the triflate and
then treated with primary amine to afford the secondary t
uamine. Reaction of the resulting secondary amine with
different acylation agents generated compound 11.7 n
1with the third diversity point. Pauson-Khand reaction
on 11.7 resulted in the tricyclic α,β-unsaturated ketone, c
t11.8, which was further subjected to a hetero-Michael
reaction to insert the fourth point of diversity, yielding n1.9. Finally, treatment of macrobeads with HF-pyridine
esulted in the tricyclic compound, 11.10, with four di-
ersity points.
With the goal of obtaining skeletal diversity, Schreiber
nd coworkers [55] explored the use of a triene in
ycloaddition reactions. The triene synthesis followed
he work of the Fallis group [56], in which indium-medi-
ted alkylation is the key step. The substituted hydroxyl
roup could then undergo elimination, leading to the
esired triene. For model studies, 4-hydroxy-3-
ethoxybenzaldehyde was loaded onto the alkylsilyl
acrobeads, giving compound 12.1 (all 12.X com-
ounds are shown in Figure 12). Upon subjection to
ndium-mediated alkylation, followed by hydroxyl eli-
ination, the triene anchored onto a solid support
12.2) was obtained. This triene was then subjected to
ne of two reactions. In one study, the triene, 12.2, was
ubjected to a cycloaddition reaction with a disubsti-
uted dienophile that gave the bis-cycloaddition prod-
ct, 12.5, with complete stereocontrol. Interesting to
ote was the observation that the reaction of the triene,
2.2, with a trisubstituted dienophile gave only mono-
ycloaddition product 12.3. This compound could fur-
her be resubjected to cycloaddition with different die-
ophiles, giving product 12.4. This method is highly
Review
173Figure 10. Schreiber and Coworkers’ Boronic
Ester Annulation/Diels-Alder Approach
See [49, 50].12.10, 12.11, and 12.12) were confirmed in solution byp-toluenesulfonylhydrazone to obtain 12.7. Upon reac-
Figure 11. Schreiber and Coworkers’ DOS
Approach to Obtain Polycyclic Compounds
from Glycals
See [51].practical, and by using the split-and-mix synthesis pro-
tocol, an encoded library of 29,400 compounds was
obtained from different aldehydes and di-, tri-, and
tetrasubstituted dienophiles. As depicted in Figure 12,
this library was immobilized on glass slides to obtain a
small-molecule microarray [57]. In a typical experiment,
the aminopropyl silane group, 12.6, was coupled withtion with NaOMe, 12.7 gave the reactive diazobenzyli-
dene-derivatized glass surface (12.8) to which a small
molecule having an acidic proton, 12.9, could then be
immobilized. The arrayed library was then probed with
the Cy5-calmodulin fusion protein to explore the bind-
ings. Few library members were found to be active. The
binding measurements of these small molecules (see
Chemistry & Biology
174surface plasmon resonance studies. In this study, the
aprotein was immobilized on the surface, and small
molecules were brought in contact in solution. f
oIn another report [58], Schreiber and coworkers dis-
closed their result of the use of an unstable reactive t
Aintermediate (e.g., dihydroisoquinoline) in obtaining
skeletally different products. Interesting to note is their s
pfinding that, when immobilized onto the solid support,
the otherwise reactive dihydroisoquinoline system is l
tquite stable and could be stored at room temperature
for a few days. Using their previously described alkylsi- t
βlyl macrobeads, they obtained compound 13.2 from
13.1 (all 13.X compounds are shown in Figure 13). This F
awas then subjected to allylation and Grignard reaction,
giving the desired intermediate, 13.3. A few examples m
pof the skeletally different products they obtained (13.4,
13.5, 13.6, and 13.7) are also shown. sFigure 12. An Asymmetric Cycloaddition Ap-
proach by Schreiber and Coworkers
(A) A cycloaddition approach with triene to
obtain polycyclic compounds.
(B) An approach to immobilize small mole-
cules having an acidic proton on an amino-
propyl glass surface by Schreiber and co-
workers.
(C) Few library members identified as Cal-
modulin protein binding agents.
See [55, 57].Due to its presence in a wide variety of bioactive,
lkaloid natural products, the tetrahydroquinoline scaf-
old is considered to be privileged ([59]; see Chapter 6
n Alkaloids). The extensive usefulness of quinoline- and
etrahydroquinoline-based natural products prompted
rya and coworkers [60] to develop a diversity-oriented
ynthesis program to obtain rapid access to natural
roduct-like, polycyclic derivatives having this privi-
eged structure. The first milestone toward this objec-
ive was to develop an efficient enantioselective syn-
hesis of highly functionalized, tetrahydroquinoline-based
amino acid, 14.1 (all 14.X compounds are shown in
igure 14). The phenolic hydroxyl group could be used
s an anchoring site in solid-phase synthesis. The re-
aining functional groups could then be utilized to ex-
lore the three-dimensional chemical space around this
caffold, thus leading to the synthesis of skeletally dif-
Review
175Figure 13. An Application of Immobilized Di-
hydroisoquinoline to Obtain Skeletally Dif-
ferent Compounds
See [60].and C4#-H.like, polycyclic compounds. Although the tetrahydro-
Figure 14. Arya and Coworkers’ Stereocon-
trolled DOS to Obtain Tetrahydroquinoline-
Derived, Natural Product-like, Polycyclic Com-
pounds
See [60].ferent, complex, polycyclic derivatives such as 14.2,
14.3, and 14.4. Tricyclic compound 14.2, having a
6-membered enamide functional group, could be ob-
tained from 14.1 through an RCM approach. For the
library generation, the enamide moiety could then be
subjected to asymmetric, diversity-oriented reactions.
In another approach, after the modification of the side
chain of 14.1, resulting in the incorporation of the allylic
hydroxyl group, an additional 8-membered ring con-
taining an enamide functional group, 14.3, could be
generated. Tetrahydroquinoline-derived tricyclic deriv-
ative, 14.3, could then be further exploited in ring con-
formation-controlled, asymmetric, diversity-oriented re-
actions. The incorporation of the medium-sized ring in
polycyclic skeletons could be highly attractive for
further derivatization on solid phase. Finally, one could
envision that the synthesis of the bridged tricyclic de-
rivative, 14.4, could be derived from a regio- and ste-
reoselective conjugate addition. Thus, using the com-
mon precursor, 14.1, it is possible to obtain skeletally
different tricyclic derivatives, 14.2, 14.3, and 14.4, that
could further be utilized to generate libraries of func-
tionalized tetrahydroquinoline-derived natural product-quinoline moiety is present in all three scaffolds, these
scaffolds are structurally distinct and occupy different
chemical spaces.
As a model study, Arya and coworkers developed an
enantioselective synthesis of tetrahydroquinoline β amino
acid [60]. Using an RCM approach, the tetrahydroquin-
oline-derived tricyclic compound having an enamide
functional group was obtained in solution and on solid
phase. For the solid-phase synthesis, compound 15.1
(all 15.X compounds are shown in Figure 15), having a
free hydroxyl group, was selected. This compound was
synthesized in a similar manner to the studies carried
out in the model system. Compound 15.1 was first an-
chored onto the solid support by using 4-(bromometh-
yl)phenoxymethyl polystyrene resin (loading 93%) to
give 15.2. Following the N-alloc removal and acryloyla-
tion, the RCM reaction gave the cyclic enamide product
on solid phase. As observed in solution studies, com-
pound 15.4 was obtained as a single diastereomer (at-
tack from the α face) upon reaction with PhSH after
cleavage from the solid support (27% overall yield for
six steps). The nuclear magnetic resonance (NMR)
studies with compound 15.4 showed nOe between C3-H
Chemistry & Biology
176Figure 15. Ring-Closing Metathesis Approach
by Arya and Coworkers
(A) RCM approach to obtain natural product-
like, polycyclic compounds.
(B) Regio- and stereoselective hetero-Michael
approach to tetrahydroquinoline-based, poly-
cyclic compounds.
(C) Stereocontrolled solid-phase synthesis
of tetrahydroquinoline-based, natural prod-
uct-like, polycyclic compounds.
See [60].In a model study to explore the regio- and stereosel-
cective hetero-Michael approach shown in Figure 15, an
enantiorich, tetrahydroquinoline β amino acid was con- t
dverted through a series of simple transformations into
the hydroxyl derivative, 15.6. With compound 15.7 as the w
Tstarting material, the stage was now set to explore the
asymmetric hetero-Michael reaction. The researchers v
twere pleased to note that this reaction proceeded very
smoothly and produced only a single diastereomer, s
g15.8, in high yield (84%). The tetrahydroquinoline-
based tricyclic derivative, 15.8, was well characterized t
lby mass spectrometry (MS) and NMR. As observed
earlier, this reaction seems to be independent of the l
choice of the base and is an excellent example of a
highly regio- and stereoselective (reaction with ben- a
pzylic-OH at C4 only) hetero-Michael reaction. Based
upon extensive NMR studies that showed no nOe be- t
btween C2-H and C4-H (note: compound 15.7 showed
nOe between C2-H and C4-H), a boat-like structure for i
βthe newly formed pyran ring, 15.9, via the boat-like
transition state, was proposed. The regio- and stereo- F
fselective outcome could be envisioned by a pseudo-
axial occupation of functional groups at C-2, C-3, and m
sC-4, allowing a facially selective attack of the oxygen
nucleophile onto the conjugated carboxyl ester site. tFor the solid-phase synthesis of 15.13 (Figure 15),
ompound 15.11 was immobilized onto the resin as in
he previous example (loading 86%). The free hydroxyl
erivative, 15.12, obtained after acetonide removal,
as subjected to the crucial hetero-Michael reaction.
he use of NaH as a base at room temperature pro-
ided the expected product, 15.13, after cleavage from
he support. As observed in the solution-phase synthe-
is (see compound 15.14), this yielded the unusual re-
io- and stereoselective hetero-Michael product. The
wo examples discussed above could be further uti-
ized in the generation of a library of tetrahydroquino-
ine-based, natural product-like, polycyclic compounds.
As reported by Arya and coworkers [61], the last ex-
mple of tetrahydroquinoline-derived, polycyclic com-
ounds is the solution- and solid-phase synthesis of
ricyclic derivatives having a functionalized 8-mem-
ered ring with an enamide functional group. As shown
n Figure 16, enantio-rich, tetrahydroquinoline-derived
amino acid 16.1 (all 16.X compounds are shown in
igure 16) was converted into 16.2, a starting material
or the solid-phase synthesis. This compound was im-
obilized onto the resin as described before and then
ubjected to a series of reactions as follows: (i) acetyla-
ion, (ii) N-alloc removal, and (iii) acryloylation. Upon
Review
177Figure 16. Stereocontrolled Diversity-Orien-
ted Reactions
(A) Tetrahydroquinoline-derived, polycyclic
compounds having a functionalized 8-mem-
bered ring.
(B) Ring conformation-controlled, asymmet-
ric conjugate addition.
See [61].subjection to a second generation Grubbs’ catalyst, a
successful synthesis of a medium-sized ring having an
enamide functional group, 16.4, was achieved. Finally,
compound 16.5 was obtained after cleavage from the
solid support and was thoroughly characterized by 2D
NMR studies after purification by column chromatogra-
phy. The solution-phase synthesis of the related com-
pounds, 16.6 and 16.7, was also achieved in parallel for
comparison. An example of ring conformation-con-
trolled asymmetric conjugate addition with the thiol as
a nucleophile is shown in Figure 16. As expected, the
major products, 16.8 and 16.10, from compounds 16.6
and 16.7 resulted from the approach of the nucleophile
from the β face. Once again, the products were well
characterized by 2D NMR studies.
With few exceptions [62–65], there are not many ex-
amples of library generation of macrocyclic derivatives
or small molecules having functionalized medium-sized
rings. With the goal of obtaining a library of polycyclic
compounds having a functionalized macrocycle, Arya
and coworkers [66] reported the solution- and manual-
solid-phase synthesis of tetrahydroquinoline-based tri-
cyclic derivatives having a functionalized 10-membered
ring. Starting from the enantio-rich compound, 17.1 (all
17.X compounds are shown in Figure 17), the plan was
to immobilize 17.2 onto the solid support, giving 17.3.RCM with the use of a second generation Grubbs’ cata-
lyst was the key reaction in this approach. Obtained
from 17.3, compound 17.4 could then be subjected to
RCM, giving the bridged, 10-membered ring having an
enamide functional group. This functional group could
further be utilized in asymmetric diversity-oriented re-
actions.
Compound 17.6 (Figure 17), having a free phenolic
hydroxyl group, was used for developing a solid-phase
synthesis. The solid-phase synthesis was carried out
on the bromo-Wang resin (1.70 mmol/g), and the load-
ing of the phenolic derivative, 17.6, was accomplished
nicely (85% loading after cleavage of the product from
the solid support). Following immobilization, 17.7 was
then subjected to O-alloc removal under basic condi-
tions (NaOMe), giving the free secondary hydroxyl
group. This derivative was then acylated with pentenoic
acid (diisopropylcarbodiimide, 4-dimethylaminopyridine).
To obtain a precursor of the RCM, the N-alloc group
was deprotected, and the free amine was acylated with
acryloyl chloride, giving compound 17.8. When sub-
jected to RCM reaction conditions, compound 17.8
nicely gave the bicyclic product, 17.9, with a function-
alized, bridged, 10-membered ring. Following cleavage
from the support and purification by column chroma-
tography, product 17.10 was well characterized by
Chemistry & Biology
178Figure 17. Natural Product-like Compounds
with a Bridged, Medium-Sized Ring
(A) Tetrahydroquinoline-based polycyclics
having a functionalized, bridged, 10-mem-
bered ring.
(B) Solid-phase synthesis of tetrahydroquin-
oline-based, polycyclic compounds with a
bridged, 10-membered ring.
See [66].NMR and MS. It was therefore possible to obtain on c
tsolid phase a natural product-like, tetrahydroquinoline-
derived, polycyclic compound having a functionalized,
10-membered ring whose novel scaffold could be uti-
Alized in library generation.
O
c
Conclusions g
tWith the growing interest in having rapid access to
fsmall molecules used as (i) chemical probes for under-
vstanding ligand-protein interactions and as (ii) modula-
a
tors of protein-protein interactions, generating natural c
product-like small molecules that are skeletally diverse, v
structurally complex, and rich in stereogenic functional t
agroups is attracting attention. The early days of combi-
lnatorial chemistry were originally devoted to obtaining
simple, flat, aromatic-based compounds. However, the
Rneed to develop efficient stereo- and enantioselective
R
methods that use the tools of modern organic synthe- A
sis is now in demand. In the combinatorial chemistry P
arena, diversity-oriented synthesis is aimed at meeting
Rthese challenges. To meet the emerging biological chal-
lenges of postgenomic chemical biology, the develop-
ment of novel, stereocontrolled, diversity-oriented syn-
thetic methods is likely to play a key role in the
generation of libraries of small molecules with the de-
sired characteristics. From the examples discussed in
this review, it is evident that the synthetic community is
prepared to meet these challenges, and it is likely that
we will see a rise in activity in this area in the coming
years. It will be interesting to see what the future value
of exploring the new chemical space that is not cur-
rently available to the biological community will be, and
how these types of small molecules will compare to the
presently available chemical space seen in nature.
Whatever the outcome of this venture, the syntheticommunity is well positioned to undertake some of
hese challenges.
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